Epilepsy and associated mortality in patients with multiple sclerosis

Area of Science:

• Neurology
• Epidemiology
• Clinical Research

Background:

• Multiple sclerosis (MS) is a chronic neurological disease.
• Epilepsy is a common neurological comorbidity in MS.
• Understanding the relationship between MS and epilepsy is crucial for patient care.

Purpose of the Study:

• To determine the prevalence of epilepsy in patients diagnosed with MS.
• To assess the risk of developing epilepsy after an MS diagnosis.
• To evaluate the impact of epilepsy on mortality risk in MS patients.

Main Methods:

• Utilized the UK Clinical Practice Research Data-link for a population-based study.
• Identified 2526 patients with incident MS and matched them with 9980 controls.
• Employed logistic and Cox regression analyses to estimate odds and hazard ratios.

Main Results:

• Prevalence of epilepsy at MS diagnosis was 1.30% in MS patients vs. 0.57% in controls.
• MS patients had an adjusted odds ratio of 2.11 for pre-existing epilepsy.
• The risk of developing epilepsy within 10 years was significantly higher for MS patients (2.77% vs. 0.90%).
• MS was associated with a 6.01-fold increased hazard of epilepsy.
• Epilepsy increased all-cause mortality risk by 2.23-fold in MS patients.

Conclusions:

• Patients with MS exhibit a higher prevalence of epilepsy at diagnosis.
• The risk of developing epilepsy is elevated following an MS diagnosis.
• Epilepsy in MS patients is linked to a significantly increased risk of mortality.